1-4 of 4
Jing Zhang, MSc
Close
Sort by
Journal Articles

Targeting Proteinkinase C Alters ER-Stress and b-Catenin Signaling in Multiple Myeloma: Therapeutic Implications.

Marc S. Raab, MD, Klaus Podar, MD, PhD, Jing Zhang, MSc, Giovanni Tonon, MD, Johannes H. Fruehauf, MD, Iris Breitkreutz, MD, Boris K. Lin, MD, PhD, Teru Hideshima, MD, Dharminder Chauhan, PhD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2007) 110 (11): 258.
https://doi.org/10.1182/blood.V110.11.258.258
Published: 2007
Journal Articles

The Tyrophostin Adaphostin (NSC680410) Inhibits Multiple Myeloma Bone Marrow Angiogenesis In Vitro and In Vivo.

Klaus Podar, MD, PhD, Jing Zhang, MSc, Marc S. Raab, MD, Sonia Vallet, MD, Mariateresa Fulciniti, MSc, Martin Sattler, PhD, Yutaka Ikeda, MD, PhD, Dharminder Chauhan, PhD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2007) 110 (11): 2507.
https://doi.org/10.1182/blood.V110.11.2507.2507
Published: 2007
Journal Articles

The Novel, Orally Available Multi-Kinase Inhibitor BAY 73-4506 Targets Myeloma Cells and Their Bone Marrow Microenvironment.

Marc S. Raab, MD, Iris Breitkreutz, MD, Podar Klaus, MD, PhD, Jing Zhang, MSc, Simona Blotta, MD, Olaf Christensen, MD, Teru Hideshima, MD, Dharminder Chauhan, PhD, Scott Wilhelm, PhD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2007) 110 (11): 2525.
https://doi.org/10.1182/blood.V110.11.2525.2525
Published: 2007
Journal Articles

Targeting PKC in Multiple Myeloma: In Vitro and In Vivo Effects of the Novel, Orally Available Small-Molecule Inhibitor Enzastaurin (LY317615.HCl).

Marc S. Raab, MD, Klaus Podar, MD, PhD, Jing Zhang, MSc, Douglas McMillin, PhD, Iris Breitkreutz, MD, Yu-Tzu Tai, PhD, Boris Lin, MD, PhD, Irene Ghobrial, MD, Nikhil Munshi, MD, Teru Hideshima, MD, Dharminder Chauhan, PhD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2006) 108 (11): 3466.
https://doi.org/10.1182/blood.V108.11.3466.3466
Published: 2006